AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
about
Breast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and TechnologiesNucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical scienceNucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease TherapyNucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineNovel Functionalized Selenium Nanoparticles for Enhanced Anti-Hepatocarcinoma Activity In vitro.A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinomaSynthesis and characterization of multifunctional hybrid-polymeric nanoparticles for drug delivery and multimodal imaging of cancer.Nanotechnology-based approaches in anticancer researchEnhanced Entrapment and Improved in Vitro Controlled Release of N-Acetyl Cysteine in Hybrid PLGA/Lecithin Nanoparticles Prepared Using a Nanoprecipitation/Self-Assembly Method.Polydopamine-Based Surface Modification of Novel Nanoparticle-Aptamer Bioconjugates for In Vivo Breast Cancer Targeting and Enhanced Therapeutic Effects.Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine.Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy.G4-Tetra DNA Duplex Induce Lung Cancer Cell Apoptosis in A549 CellsLipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles.Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.Lipid-enveloped hybrid nanoparticles for drug delivery.Concepts and practices used to develop functional PLGA-based nanoparticulate systemsApplication of aptamers for targeted therapeutics.Aptamers: problems, solutions and prospects.Oligonucleotide aptamers: new tools for targeted cancer therapy.Aptamers as drug delivery vehicles.Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.Targeting cancer cells with controlled release nanocapsules based on a single aptamer.Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment.Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics.Lipid-coated polymeric nanoparticles for cancer drug delivery.Biophysical characterization of layer-by-layer synthesis of aptamer-drug microparticles for enhanced cell targeting.Structurally distinct hybrid polymer/lipid nanoconstructs harboring a type-I ribotoxin as cellular imaging and glioblastoma-directed therapeutic vectors.Aptamers as Therapeutics.Study of the selective uptake progress of aptamer-modified PLGA particles by liver cells.Nanoparticle Functionalization and Its Potentials for Molecular Imaging.Biodegradable Self-Assembled Nanoparticles of Galactose-Containing Amphiphilic Triblock Copolymers for Targeted Delivery of Paclitaxel to HepG2 Cells.Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.General overview of lipid-polymer hybrid nanoparticles, dendrimers, micelles, liposomes, spongosomes and cubosomes.Aptamers and Their Significant Role in Cancer Therapy and Diagnosis.
P2860
Q26783705-D617FC88-04C5-40A4-8E36-87F7C52DA4AEQ26995510-5D724893-C06B-4C3F-8F61-577234F88DB0Q30434521-844B6FF4-07E9-468D-B717-4800A7550F18Q33681168-B273D609-50B3-4C20-9DA4-3ED12DD9F2E4Q33834772-74C26517-1D42-4813-AE97-A4B40AB449D4Q34698624-C627646D-7FBF-42C7-8144-D786AC828964Q36023716-F00D7068-B73F-4BFB-AD91-BF73BE2E96A6Q36028980-75772F0D-0A25-4406-BF1B-586C46C599CAQ36078293-307DEC6B-F338-4303-8637-F833A0615871Q36168983-2DEF6AD3-49A5-479B-BE83-EFB301D3114BQ36350003-CE0541ED-A857-4C23-AE29-FD7E9DF0BB0DQ36644318-B6C9DF78-2F10-4E8D-A6B2-25E7AE58C07DQ36946804-DF0E1188-01BD-4DD8-A660-3F8E546DBD08Q36986485-A2DDE1AB-2222-4D99-85C0-52C6989AB7EDQ37301975-C5F1A0AC-A13A-49A7-9442-5CF4A3E9D979Q37316779-F75EBF20-E978-4965-A991-70D18014EB82Q37607750-95A9C5EA-B51E-40AF-BA61-599AC5C1F53AQ37677464-C8F7A3B9-2368-4854-8ACF-9597A74433FBQ38071910-C6B70076-8B3B-49CF-9CB3-E932DAA36510Q38086377-BD2318A1-CABD-4097-AA1E-5CCD707F9BB5Q38096870-EBBEAC0C-EF33-4859-9FBA-79A70AF92375Q38181121-55A2CA9B-05EC-4FD3-BD33-F8CC937F7DBCQ38237132-8138AE26-CDE9-49C0-ACA7-88250FB0FE94Q38240594-571C706B-F539-4630-B737-849CFD8B8609Q38311680-176B24E4-7016-453B-9C84-9B7AE853FB5BQ38318762-AD009D4A-3078-42B0-86D8-AD3C4C87C8D9Q38491805-99BE1E1C-4FE1-4BDB-BE52-E2428244DA3EQ38494470-6003B774-ECF6-4B89-B732-2ED8C9A2D84CQ38504825-879EADD9-1F95-4B72-BEDC-AE87E7FEDFE1Q38556750-9B1E5750-B55D-48CC-BE7E-E73822B89144Q38682986-A69BBEEC-881B-4463-8D53-42CC0719AAAFQ38960506-6804E70C-4BC0-4640-A511-BC64C2EC7650Q39070782-F5A87B6B-B283-457F-A765-D74E8059D7B3Q39123634-38512832-5EC7-466E-AB5B-2781DCB730C2Q39194848-56D59C33-DA44-445D-9CEA-E22A3E32C3C4Q40034701-7CF36C96-4A9D-421A-924E-623F38CA9596Q41953738-22AD3C1F-EBF6-4A11-8EDF-AEA7FD7B06B5Q48025703-E9945CDD-339B-4AEF-B13B-C75BF26A481AQ48257489-4B155BB8-2A9D-430E-A21A-69DA4DDDBB60Q54457076-C590838F-ABD0-498D-8867-0ED7B1C89A8A
P2860
AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.
@ast
AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.
@en
AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.
@nl
type
label
AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.
@ast
AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.
@en
AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.
@nl
prefLabel
AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.
@ast
AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.
@en
AS1411 aptamer tagged PLGA-lec ...... l targeting and drug delivery.
@nl
P2093
P2860
P356
P1476
AS1411 aptamer tagged PLGA-lec ...... ll targeting and drug delivery
@en
P2093
Athulya Aravind
Prashanti Jeyamohan
Remya Nair
Srivani Veeranarayanan
Toru Maekawa
Yasuhiko Yoshida
Yutaka Nagaoka
P2860
P304
P356
10.1002/BIT.24558
P577
2012-06-01T00:00:00Z